Overall, researchers found, women were less likely to undergo coronary angiography, percutaneous coronary intervention and mechanical circulatory support than men.

Patients who received TAVR and PCI experienced lower rates of mortality and fewer major bleeding events than those treated with SAVR and CABG. 

The World Heart Federation, American College of Cardiology and American Heart Association all announced how they are celebrating the big day. 

The analysis, written by representatives of the American Heart Association, focused on SGLT2 inhibitors and GLP-1 receptor agonists.

Researchers developed and implemented a four-step process for identifying patients who can be discharged early following PCI. 

The authors did emphasize that they were not ruling on the overall “clinical efficacy” of hydroxychloroquine with this research. 

Researchers wrote that they observed "substantial and increasing disparities in CVD between people with the most resources and the remainder of the U.S. population."

The latest evidence of COVID-19's cardiovascular impact on patients comes from a new imaging study published in the American Journal of Roentgenology.

The study's authors identified dozens of potential new biomarkers, sharing their findings in the Proceedings of the National Academy of Sciences.

Gary Idelchik, MD, has filed a lawsuit against BayCare Health System in Florida.